Prediction model for T lymphocyte content in single blood sampling and application of prediction model

By using T lymphocyte content prediction model in single blood collection, using calculation formulas I and II to predict the number and collection volume of T lymphocytes in peripheral blood, the inadequate collection of T lymphocytes and the dependence on the success of T lymphocytes in the prior art was solved. The problem has achieved a safer and resource-saving collection process.

CN118942529AInactive Publication Date: 2024-11-12SUZHOU NEWPORT TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410918646.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-10
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the prior art, when collecting large amounts of T lymphocytes required for CAR-T cell therapy, conventional peripheral blood collection methods cannot effectively obtain sufficient quantities, and the success of the collection depends on the experience of medical staff, which poses waste of resources and safety risks.

Method used

A prediction model of T lymphocyte content in single blood collection is provided, and T lymphocytes that can be collected per unit volume of peripheral blood are calculated by calculating formula I (N1 = 4.67 × 105 × C + 108 cells) and formula II (V0 = N0/N1) Quantity and preset collection volume simplify collection plan and reduce errors.

Benefits of technology

Relatively accurate prediction of T lymphocyte collection results has been achieved, and scientific and complete collection plans have been formulated to protect donors or patients to the greatest extent, and reduce resource waste and safety risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004935932770000041
    Figure BDA0004935932770000041
  • Figure BDA0004935932770000071
    Figure BDA0004935932770000071
Patent Text Reader

Abstract

The invention relates to the technical field of biology, in particular to a prediction model for the content of T lymphocytes in single blood sampling and application of the prediction model. The number of peripheral blood T lymphocytes in unit volume of a donor or a patient and the preset collection volume of peripheral blood are obtained through the prediction model formed by a calculation formula designed in the application; according to the method, the acquisition result can be predicted relatively accurately, so that a more scientific and perfect acquisition scheme is guided to be formulated, the body safety of a donor or a patient is protected to the greatest extent, and resource waste is reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biotechnology, and in particular to a prediction model for T lymphocyte content in single blood collection and its application. Background Art

[0002] Currently, CAR-T cell therapy requires a large number of T lymphocytes as starting materials, and T lymphocytes generally need to reach 10 8 The conventional method of collecting peripheral blood is unable to collect enough T lymphocytes. Currently, only single collection by a blood cell separator can obtain a sufficient number of T lymphocytes.

[0003] T lymphocyte apheresis is to draw the donor's peripheral blood from the body into the disposable tube of the blood cell separator, and use the centrifugal principle to separate the blood components into layers according to the different cell sizes and densities. The required T lymphocytes are extracted, and the other blood components are returned to the donor. This can not only obtain the required blood components, but also ensure that the donor does not have the risk of excessive blood loss. It is one of the best ways to obtain a large number of T lymphocytes.

[0004] In practice, there are large differences in the physical condition and previous treatment history of donors or patients. In order to achieve the expected number of T lymphocytes, a complete collection plan needs to be formulated before collection, such as the volume of circulating peripheral blood and the collection time. However, whether the collection can be successful in the end often depends on the experience and judgment of medical staff, which has a large error. If the collection fails, not only time and material costs are wasted, but also the donor or patient suffers unnecessary safety risks. Summary of the invention

[0005] The purpose of this application is to overcome the shortcomings of the above-mentioned prior art and provide a prediction model for the content of T lymphocytes in a single blood sample and its application. Before starting the single blood collection, the number of peripheral blood T lymphocytes per unit volume of the donor or patient obtained by the calculation formula designed in this application can relatively accurately predict the collection result, thereby guiding the formulation of a more scientific and complete collection plan, protecting the physical safety of the donor or patient to the greatest extent, and reducing resource waste.

[0006] To achieve the above purpose, the technical solution adopted by this application is:

[0007] The present application provides a prediction model for the content of T lymphocytes in a single blood sample, wherein the prediction model uses the following calculation formula I to predict the number of T lymphocytes:

[0008] Calculation formula I: N1 = 4.67 × 10 5 ×C+10 8 cells;

[0009] C represents the concentration of T lymphocytes in the peripheral blood of the donor or patient;

[0010] N1 represents the number of T lymphocytes that can be collected per 1L of peripheral blood processed.

[0011] After extensive research and experiments, the inventors of the present application have discovered that the above-mentioned calculation formula can be used to predict the number of T lymphocytes that can be collected from a unit volume of peripheral blood. Compared with the total number of T lymphocytes collected by actual tests, the data are very similar. Before starting a single blood collection, the collection result can be predicted relatively accurately without considering factors such as the volume of circulating peripheral blood, the collection time, and the experience and judgment of medical staff. The prediction method is simple and accurate. By using the above-mentioned method, a more scientific and complete collection plan can be formulated to protect the physical safety of donors or patients to the greatest extent and reduce waste of resources.

[0012] As a preferred embodiment of the prediction model for the content of T lymphocytes in a single blood sample described in the present application, the prediction model also includes a calculation formula II for predicting the volume of collected peripheral blood:

[0013] Calculation formula II: V0 = N0 / N1;

[0014] V0 represents the preset collection volume of peripheral blood, unit: L;

[0015] N0 represents the total number of T lymphocytes collected.

[0016] The present application obtains the number of T lymphocytes that can be collected per 1L of peripheral blood processed by the above calculation formula I, and then uses calculation formula II to directly obtain the preset collection volume of peripheral blood, thereby avoiding waste of resources and reducing safety risks for donors or patients.

[0017] As a preferred embodiment of the prediction model for the content of T lymphocytes in single blood samples described in the present application, the T lymphocyte concentration in the peripheral blood of the donor or patient represented by C is obtained by AO / PI fluorescent staining counting method.

[0018] As a preferred embodiment of the prediction model for the content of T lymphocytes in a single blood sample described in the present application, the total number of T lymphocytes collected as represented by N0 is obtained by AO / PI fluorescent staining counting method.

[0019] As a preferred embodiment of the prediction model for the content of T lymphocytes in a single blood sample described in the present application, the collection volume of peripheral blood from the donor or patient in C is 0.1 to 1 mL.

[0020] As a preferred embodiment of the prediction model for the content of T lymphocytes in a single blood sample described in the present application, the prediction model is detected using a blood cell separator.

[0021] As a preferred embodiment of the prediction model for the content of T lymphocytes in single-sample blood described in the present application, the blood cell separator includes a Fresenius Kabi COM.TEC model blood cell separator, the software version number is 02.01.11, the pipeline model is P1YA, and the pipeline batch number is 9400438.

[0022] The present application also provides the application of the above prediction model in detecting the content of T lymphocytes.

[0023] By using the calculation formula I and calculation formula II designed in the present application, the T lymphocyte content and the volume of peripheral blood to be collected can be effectively predicted, providing a scientific and complete collection plan.

[0024] Compared with the prior art, this application has the following beneficial effects:

[0025] The present application provides a prediction model for the content of T lymphocytes in a single blood sample and its application. Before starting the single blood collection, the prediction model formed by the calculation formula designed in the present application is used to obtain the number of peripheral blood T lymphocytes per unit volume of the donor or patient and the preset collection volume of peripheral blood. The collection result can be predicted relatively accurately, thereby guiding the formulation of a more scientific and complete collection plan, protecting the physical safety of the donor or patient to the greatest extent, and reducing resource waste. DETAILED DESCRIPTION

[0026] In order to better illustrate the purpose, technical solutions and advantages of the present application, the present application will be further described below in conjunction with specific embodiments.

[0027] In the following examples, the experimental methods used are conventional methods unless otherwise specified, and the materials, reagents, etc. used are all commercially available unless otherwise specified.

[0028] The present application provides a prediction model for the content of T lymphocytes in a single blood sample, wherein the prediction model uses the following calculation formula to predict the content of T lymphocytes;

[0029] Calculation formula: N1 = 4.67 × 10 5 ×C+10 8 cells;

[0030] C represents the concentration of T lymphocytes in the peripheral blood of the donor or patient (×10 6 cells / L);

[0031] N1 indicates the number of T lymphocytes that can be collected by the blood cell separator for every 1L of peripheral blood processed.

[0032] The prediction model also includes a calculation formula for predicting the volume of peripheral blood collected:

[0033] Calculation formula: V0 = N0 / N1;

[0034] V0 represents the preset collection volume of peripheral blood, unit: L;

[0035] N0 represents the total number of T lymphocytes collected.

[0036] Before starting single blood collection, the present application obtains the T lymphocyte content in the single blood collection by measuring the peripheral blood T lymphocyte concentration per unit volume of the donor or patient, and can relatively accurately predict the collection result, thereby guiding the formulation of a more scientific and complete collection plan, protecting the physical safety of the donor or patient to the greatest extent, and reducing waste of resources.

[0037] Example 1

[0038] 1. Laboratory tests and vital signs examination before collection:

[0039] Before collection, the donors in this example were subjected to laboratory examinations and vital signs examinations, and the donor conditions are shown in Table 1:

[0040] Table 1

[0041]

[0042] 2. Choice of vascular access establishment method:

[0043] The donor's vascular condition must be evaluated in advance to determine the specific method of pipeline access. Medical staff who implement pipeline access must be trained and qualified. The choice of blood vessels is the key to whether the collection process is smooth and the quality of the collection is good or bad. The outflow blood vessels generally choose the median cubital vein, basilic vein, and cephalic vein of the upper limb. The return blood vessels can choose the contralateral median cubital vein, cephalic vein, and great saphenous vein on the medial side of the left and right ankles. The basilic vein is characterized by thin walls, less smooth muscle and elastic fibers, poor contractility and elasticity, and slow blood flow. Therefore, the basilic vein is generally not selected for the return blood vessels of venous puncture. While ensuring the normal circulation rate, the low-risk peripheral vascular access method should be used as much as possible. When the donor's peripheral blood vessels do not meet the access requirements, a combination of peripheral vascular access and central venous catheterization (CVC) or central venous catheterization is used. Special attention should be paid to infection protection issues.

[0044] 3. Instrument startup procedure:

[0045] The Fresenius Kabi COM.TEC blood cell separator was used, the software version number was 02.01.11, the pipeline model was P1YA, and the pipeline batch number was 9400438.

[0046] Turn on the power switch on the upper right side of the system and the system will perform a self-test to verify that the hard drive and software are functioning properly. Once the self-test is complete, the system will activate the on-screen buttons and you can start running programs.

[0047] 4. Select the program:

[0048] Touch the "Select Program" key and the program selection screen will appear. Touch the "Mononuclear Cell Collection (PBMC)" key, then touch the "Confirm" key and the system will load the program software and return to the program preparation screen.

[0049] 5. Installation and pre-flushing pipelines:

[0050] 5.1 Check the expiration date on the packaging envelope to confirm whether the pipeline is expired. Check the integrity of each consumable and make sure it is not damaged before use. Touch the "Pipeline Preparation" key and the pipeline preparation screen will appear.

[0051] 5.2 Remove the pipeline packaging envelope, take out the product bag, plasma bag, and exhaust bag, and hang them from the right side in turn, take out the anticoagulation pipeline (orange needle) and saline (green needle), and hang them above the left side of the system.

[0052] 5.3 Take out the cassette and separation tank and place them on the centrifuge cover. Place the cassette on the fixed plate, making sure there is no object behind the cassette or fixed plate that will hinder the installation.

[0053] 5.4 Hang the bags on the IV stand in the following order from left to right: exhaust bag, plasma bag, collection bag.

[0054] 5.5 Open the centrifuge door, straighten the tubing to avoid twisting, turn the loading port to the lower right corner of the operator, push the separation tank up through the loading port and the opening in the center of the separation tray, lower the separation tray latch and lock it in place. Position the lower sleeve on the separation tray latch so that the pink tubing is not blocked by other tubing. Push the sleeve into the sleeve holder until you hear the locking pin make a "click" sound, at which time the pin protrudes and locks the sleeve. Starting from the separation tank connection port, press the separation tank into the groove on the separation tray and finally end at the blood collection port. Slide the separation tank by hand to check whether it is fully inserted into the groove. The separation tank must remain flush with the groove. Place the blood collection chamber into the collection chamber holder, making sure that the collection chamber is behind the clamp of the holder opening. Place the collection chamber tubing behind the edge of the optical reference to ensure that the tubing does not block the optical reference. Push the narrow portion of the lower cannula into the lower cannula holder and the narrow portion of the upper cannula into the upper cannula holder, making sure the braided portion of the loop is not twisted, using the upper cannula under the upper cannula holder, install the tubing into the holder, then pull the tubing up to secure the upper cannula in the holder. Rotate the centrifuge clockwise to ensure it rotates freely. Close the centrifuge door. Once the centrifuge door is closed, touch the "Load" key and the system will lower the cassette.

[0055] 5.6 Test the pipeline: clamp the pipeline connected to the diversion bag, close the saline inlet pipeline and the return pipeline, clamp the pipeline connected to the sampling bulb; touch the "Continue" button, clamp the blood collection blood pipeline and the return pipeline; touch the "Continue" button, the system will perform multiple tests to verify whether the pipelines and system components are working properly and whether the pipelines are installed correctly.

[0056] 5.7 Priming the lines: Puncture the liquid container, fill the drip pot, place the anticoagulant line in the anticoagulant detector; touch the "Start Priming" key, the system will prime the anticoagulant line; open the saline inlet line and the return line; touch the "Continue" key, the system will prime the return line, blood collection tube, red blood cell tube and separation tank. When the system completes the priming, a prompt sound will be issued and the donor data screen will appear.

[0057] 6. Enter and confirm donor information

[0058] The volume to be collected is calculated based on the following calculation model.

[0059] N1=4.67×10 5 ×C+10 8 cells

[0060] V0=N0 / N1

[0061] V0 represents the preset collection volume (unit: L), N0 represents the total number of T lymphocytes to be collected or the final total number of T lymphocytes to be collected, N1 represents the number of T lymphocytes that can be collected by the blood cell separator for every 1 L of peripheral blood processed, and C represents the concentration of T lymphocytes in the donor's peripheral blood (×10 6 cells / L).

[0062] Touch the keys on the screen to enter the donor information (double check), touch the "Confirm" key, and the collection preferences screen will appear. Touch the "Preferences" key, enter the collection preference values, and the run value screen will appear. Review the run values ​​displayed on the screen and make sure the final values ​​are correct. To collect plasma while running, enter the amount of plasma to be collected. To change the value, follow the pre-calculated parameter value, touch the key corresponding to the value, and finally touch the "Confirm" key.

[0063] 7. Start the program:

[0064] Empty the saline drip pot and rehang the saline container. Touch the "Confirm" key. Prime the blood collection tube and return line, clamp the blood collection tube and return line, close the saline entry line, touch the "Confirm" key, and the connect customer screen appears.

[0065] 8. Connect with donors:

[0066] According to the vascular access method, connect the donor to the line, loosen the vascular line, touch the "Start Run" key, close the saline return line, and touch the "Continue" key. Empty the saline drip pot and rehang the saline container, and touch the "Continue" key. Loosen the return line and touch the "Continue" key. The system begins to draw the client's blood into the line and displays the main run screen.

[0067] 9. Collection and return procedures:

[0068] After completing a collection, the collection and bagging screen will automatically appear. Touch the "Collect and Bag" key and then the "Apply" key. After completing the collection and bagging, touch the "Reinfusion" key, then the "Run Reinfusion" key and then the "Confirm" key. Clamp the blood collection tube line and touch the "Continue" key. Open the saline entry line and then touch the "Continue" key. The reinfusion status screen will appear.

[0069] 10. Complete the procedure:

[0070] Close saline inlet, clamp blood and return lines, disconnect donor, seal anticoagulant, saline, and bag lines. Touch the Unload key, the system confirms blood and return lines are clamped, and then the cassette is raised. The program summary screen appears. Perform data logging, touch the New Program key on the second page, and the system will reset. Power off.

[0071] 11. Post-collection care:

[0072] After the collection is completed, remove the puncture needle. The needle hole is prone to bleeding. Apply local pressure with a sterile cotton ball for more than 15 minutes and protect it with a sterile dressing. The donor lies quietly and continues to observe blood pressure, pulse, breathing and any discomfort. Pay attention to the occurrence of adverse reactions and complications. Carefully fill in various registration books and collection nursing records, and closely observe the vital signs of the donor. Because some adverse reactions are delayed reactions, the donor should be told to report any discomfort in time. Do not do heavy physical labor or strenuous exercise within 1 week, avoid colds, continue to use a high-nutrition diet and get enough rest. Recheck the blood routine 2 to 3 days after collection to guide the test results to be normal.

[0073] The total number of T lymphocytes collected by the above calculation model (N1, cells) was compared with the total number of T lymphocytes actually collected (N0, cells). The results are shown in Table 2.

[0074] The total number of T lymphocytes actually collected (N0, cells) was obtained by AO / PI fluorescence staining counting method.

[0075] Table 2

[0076]

[0077] By comparing the total number of T lymphocytes actually collected (N0, cells) with the total number of T lymphocytes theoretically collected by this calculation model (N1, cells), it can be seen that the calculation model obtained in this application has a good prediction effect and provides a good reference for actual single blood collection.

[0078] When collecting cells according to the existing detection scheme, there is no reasonable prediction model. Researchers can only extend the collection time and increase the collection volume so that the number of cells collected can meet the expectations. The amount of cells collected often exceeds expectations, which undoubtedly puts the donor at risk of longer collection time and wastes medical resources. In addition, in autologous treatment, some patients are affected by the disease and treatment, and the T lymphocyte content in the peripheral blood is low. This model can be used to predict whether they can meet the collection requirements, so as to avoid unnecessary collection activities and reduce safety risks.

[0079] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present application rather than to limit the scope of protection of the present application. Although the present application has been described in detail with reference to the preferred embodiments, ordinary technicians in this field should understand that the technical solution of the present application can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present application.

Claims

1. A prediction model for the content of T lymphocytes in a single blood sample, characterized in that: The prediction model uses the following calculation formula 1 to predict the number of T lymphocytes: Calculation formula I: N1 = 4.67 × 10 5 ×C+10 8 cells; C represents the concentration of T lymphocytes in the peripheral blood of the donor or patient; N1 represents the number of T lymphocytes that can be collected per 1L of peripheral blood processed.

2. The prediction model according to claim 1, characterized in that The prediction model also includes a calculation formula II for predicting the volume of collected peripheral blood: Calculation formula II: V0 = N0 / N1; V0 represents the preset collection volume of peripheral blood, unit: L; N0 represents the total number of T lymphocytes collected.

3. The prediction model according to claim 1, characterized in that The T lymphocyte concentration in the peripheral blood of the donor or patient represented by C is obtained by AO / PI fluorescent staining counting method.

4. The prediction model according to claim 2, characterized in that The total number of T lymphocytes target collected represented by N0 is obtained by AO / PI fluorescent staining counting method.

5. The prediction model according to claim 1, characterized in that The amount of peripheral blood collected from the donor or patient in C is 0.1 to 1 mL.

6. The prediction model according to claim 1, characterized in that The prediction model is tested using a blood cell separator.

7. The prediction model according to claim 6, characterized in that The blood cell separator includes a Fresenius Kabi COM.TEC blood cell separator, with a software version number of 02.01.11, a pipeline model of P1YA, and a pipeline batch number of 9400438.

8. Use of the prediction model according to any one of claims 1 to 7 in detecting T lymphocyte content.